lactococcu
lacti
previous
propos
vaccin
platform
safe
deliveri
heterolog
antigen
util
l
lacti
live
vector
express
listeriolysin
llo
major
listeria
monocytogen
antigen
virul
factor
varieti
plasmid
construct
design
permit
either
constitut
nisininduc
express
secret
nonsecret
llo
l
lacti
recombin
strain
subsequ
test
murin
model
vaccin
efficaci
l
monocytogen
infect
lymphocyt
specif
llo
epitop
detect
strain
administ
via
intraperiton
ip
oral
rout
challeng
live
l
monocytogen
reveal
differ
level
protect
among
three
vaccin
strain
test
nisininduc
llosecret
l
lacti
strain
provid
greatest
protect
secondari
infect
work
highlight
use
gra
gener
regard
safe
organ
l
lacti
basi
live
vaccin
vector
l
monocytogen
work
suggest
lloexpress
l
lacti
strain
may
also
potenti
act
platform
direct
coexpress
antigen
toward
cytosol
mhc
class
pathway
enhanc
stimul
tcell
respons
listeria
monocytogen
caus
agent
listeriosi
foodborn
pathogen
infect
immunocompromis
individu
caus
mening
septicemia
pregnant
women
particularli
suscept
develop
flulik
symptom
follow
chorioamnion
miscarriag
although
l
monocytogen
infect
gener
sporad
commun
sever
largescal
commonsourc
outbreak
occur
worldwid
listeriosi
establish
infect
host
mortal
rate
high
term
human
mortal
l
monocytogen
consid
among
signific
bacteri
caus
foodborn
diseas
moreov
l
monocytogen
also
caus
infect
cattl
sheep
result
appreci
loss
foetal
infect
spontan
abort
anim
infect
farm
anim
also
consid
pose
zoonot
threat
human
may
expos
l
monocytogen
contamin
milk
meat
product
l
monocytogen
intracellular
pathogen
uniqu
mechan
cellular
infect
upon
phagocytosi
pathogen
secret
hemolysin
listeriolysin
llo
form
pore
phagosom
membran
enabl
bacterium
access
host
cell
cytoplasm
express
specif
virul
factor
includ
acta
hpt
plcb
l
monocytogen
replic
move
within
cytosol
spread
cell
cell
without
exposur
extracellular
milieu
investig
immun
respons
l
monocytogen
show
addit
role
intracellular
pathogenesi
llo
major
immunodomin
listeri
antigen
inde
protect
immun
l
monocytogen
depend
cytotox
cellmedi
immun
epitop
two
major
virul
factor
llo
central
role
llo
listeri
infect
cycl
coupl
signific
antigen
protein
indic
llo
may
potenti
basi
vaccin
l
monocytogen
live
bacteri
vector
attenu
bacillu
anthraci
aroa
salmonella
typhimurium
strain
previous
engin
express
llo
vaccin
l
monocytogen
addit
sever
attenu
l
monocytogen
mutant
investig
possibl
vaccin
listeriosi
heterolog
antigen
deliveri
system
vaccin
cancer
lactococcu
lacti
subspeci
cremori
plasmid
free
lactococcu
strain
l
lacti
nisin
produc
strain
l
lacti
l
lacti
subsp
cremori
carri
nisrk
chromosom
l
lacti
htra
l
lacti
chromosom
delet
htra
promot
end
region
htra
express
vector
use
phage
promot
ad
ntermin
sixhi
tag
express
protein
amp
r
qiagen
e
colil
lacti
shuttl
vector
contain
pnisa
promot
start
codon
ncoi
site
cm
r
deriv
contain
promot
instead
pnisa
promot
cm
r
cyto
pathogen
howev
although
efficaci
approach
clearli
demonstr
abovement
vector
base
upon
live
attenu
pathogen
may
potenti
revers
virul
state
lactococcu
lacti
gra
gener
regard
safe
microorgan
wide
use
food
industri
develop
numer
induc
constitut
express
system
l
lacti
enhanc
use
organ
cellular
factori
express
variou
heterolog
protein
biotechnolog
interest
work
extend
use
l
lacti
live
vaccin
vector
deliveri
heterolog
antigen
sever
antigen
tetanu
toxin
fragment
c
ttfc
helicobact
pylori
antigen
giardia
lamblia
cyst
wall
protein
sarscoronaviru
nucleocapsid
protein
success
express
l
lacti
promis
immunolog
outcom
follow
administr
mice
moreov
l
lacti
also
use
vehicl
deliveri
therapeut
bioactiv
substanc
includ
trefoil
factor
reduc
inflamm
enhanc
recoveri
murin
model
coliti
inde
l
lacti
strain
express
human
util
novel
biolog
contain
strategi
recent
subject
clinic
trial
patient
crohn
diseas
sinc
l
lacti
nonpathogen
noninvas
noncommens
foodgrad
bacterium
particularli
attract
basi
safe
deliveri
antigen
bioactiv
molecul
furthermor
gramposit
bacterium
l
lacti
rel
small
genom
size
exoprotein
unlik
propos
gramneg
host
produc
endotoxin
present
work
success
express
l
monocytogen
llo
l
lacti
act
potenti
live
vaccin
vector
constitut
promot
pnisa
nisininduc
promot
employ
express
llo
differ
compart
intracellular
secret
llo
express
activ
form
case
except
constitut
intracellular
form
investig
immun
respons
upon
vaccin
balbc
mice
via
intraperiton
ip
oral
rout
reveal
differ
level
llospecif
cell
igg
antibodi
protect
challeng
l
monocytogen
current
work
demonstr
applic
l
lacti
develop
potenti
vaccin
platform
l
monocytogen
summari
bacteri
strain
plasmid
use
studi
shown
tabl
luriabertani
lb
broth
use
escherichia
coli
cultur
broth
oxoid
supplement
glucos
ie
use
lactococcu
l
monocytogen
brain
heart
infus
bhi
broth
oxoid
use
technic
agar
merck
ad
wv
solid
media
requir
incub
temperatur
c
l
lacti
c
l
monocytogen
e
coli
requir
ampicillin
amp
use
concentr
gml
e
coli
chloramphenicol
cm
use
gml
e
coli
l
lacti
gml
luminesc
l
monocytogen
cell
cultur
media
reagent
obtain
gibco
unless
otherwis
state
four
plasmid
construct
express
llo
l
lacti
constitut
secllo
cytollo
plasmid
nisininduc
pnzpnisa
secllo
pnzpnisa
cytollo
plasmid
fig
plasmid
secllo
pnzpnisa
secllo
design
secret
llo
use
ntermin
secret
signal
protein
secret
lactococc
protein
use
secret
signal
previous
describ
direct
secret
heterolog
protein
l
lacti
plasmid
cytollo
pnzpnisa
cytollo
lack
secret
signal
thu
design
produc
llo
intracellularli
constitut
antigen
express
lactococc
promot
use
induc
express
pnisa
use
plasmid
use
platform
creat
four
plasmid
contain
pnisa
promot
downstream
ncoi
restrict
site
ccatgg
contain
first
start
codon
atg
howev
sinc
hli
gene
encod
llo
contain
intern
ncoi
restrict
site
modifi
elimin
ncoi
site
ad
new
start
codon
frame
hli
gene
achiev
elimin
pnisa
promot
along
ncoi
site
enzymat
digest
bglii
kpni
replac
promot
pnisa
insert
construct
without
need
ncoi
digest
fig
promoterinsert
construct
creat
use
splice
overlap
extens
soe
techniqu
primer
use
pcr
reaction
shown
tabl
pcr
reaction
perform
use
high
fidel
kod
hot
start
dna
polymeras
novagen
follow
manufactur
instruct
plasmid
use
intermedi
clone
vector
creat
sixhistidinetag
ie
histag
antigen
subsequ
clone
modifi
hli
gene
l
monocytogen
egd
access
number
minu
secret
signal
pcr
amplifi
chromosom
dna
use
forward
revers
primer
tabl
hli
gene
digest
bamhi
psti
ligat
use
dna
ligas
roch
similarli
digest
plasmid
qiagen
introduc
ntermin
sixhistidin
tag
hli
ligat
reaction
mixtur
transform
chemic
compet
e
coli
novagen
heat
shock
follow
manufactur
instruct
plate
onto
lb
agar
contain
ampicillin
coloni
pcr
use
identifi
posit
coloni
plasmid
extract
e
coli
use
qiagen
miniprep
kit
qiagen
integr
dna
sequenc
confirm
sequenc
lark
technolog
inc
uk
nisininduc
secret
llo
construct
primer
use
amplifi
promot
pnisa
use
templat
primer
use
amplifi
secret
signal
hereaft
design
sec
l
lacti
chromosom
dna
prepar
result
two
pcr
product
splice
togeth
soe
techniqu
use
primer
molar
ratio
two
pcr
product
soe
product
pnisa
sec
splice
histag
hli
gene
amplifi
use
primer
use
primer
similarli
nisininduc
nonsecret
llo
construct
primer
use
amplifi
pnisa
use
templat
subsequ
result
pnisa
soesplic
histag
hli
amplifi
use
primer
use
primer
constitut
secret
llo
construct
promot
amplifi
plasmid
use
primer
sec
signal
amplifi
l
lacti
chromosom
primer
two
pcr
product
first
splice
soe
techniqu
use
primer
result
pcr
product
splice
histag
hli
previous
amplifi
templat
use
primer
use
primer
final
constitut
nonsecret
llo
construct
creat
soe
reaction
promot
amplifi
templat
primer
histag
hli
amplifi
templat
primer
use
primer
construct
digest
sequenti
bglii
kpni
enzym
similarli
plasmid
digest
bglii
kpni
gel
extract
qiagen
gelextract
kit
qiagen
remov
interven
fragment
contain
pnisa
along
undesir
ncoi
site
fig
ligat
perform
use
dna
ligas
roch
ligat
reaction
transform
commerci
chemic
compet
e
coli
invitrogen
follow
manufactur
instruct
plate
onto
lb
agar
contain
chloramphenicol
incub
c
h
posit
coloni
detect
coloni
pcr
plasmid
extract
e
coli
use
qiagen
miniprep
kit
qiagen
dna
sequenc
confirm
lark
technolog
inc
uk
l
lacti
l
lacti
deriv
use
host
strain
cytollo
pnzpnisa
cytollo
respect
llo
secretori
plasmid
pnzpnisa
secllo
secllo
l
lacti
htra
kindli
provid
prof
airi
palva
univers
helsinki
use
host
htra
extracellular
housekeep
proteas
htradefici
lactococcu
mutant
report
effici
express
secret
protein
electrocompet
lactococcu
strain
prepar
previous
describ
transform
correspond
hlycontain
vector
use
gene
pulser
biorad
plate
onto
agar
contain
chloramphenicol
incub
c
h
coloni
check
coloni
pcr
posit
clone
preserv
glycerol
stock
c
overnight
cultur
induc
lactococcu
strain
ie
contain
pnzpnisa
secllo
pnzpnisa
cytollo
subcultur
vv
fresh
broth
grown
static
c
optic
densiti
nm
od
point
nisin
use
filtersteril
cultur
supernat
nisinsecret
strain
lactococcu
ad
concentr
vv
strain
allow
grow
h
cell
harvest
centrifug
wash
twice
phosphatebuff
salin
pb
pellet
frozen
c
analysi
constitut
strain
contain
secllo
cytollo
overnight
cultur
inocul
fresh
broth
grown
od
point
cell
similarli
harvest
wash
preserv
c
sdspage
analysi
cell
thaw
ice
resuspend
cold
lysi
buffer
mm
nah
po
mm
nacl
mm
imidazol
ph
contain
mgml
lysozym
sigma
kept
ice
min
follow
sonic
centrifug
g
min
c
aliquot
bacteri
lysat
supernat
mix
sdspage
sampl
buffer
kept
c
remain
lysat
use
purif
histag
llo
use
ninta
affin
chromatographi
cultur
supernat
llosecret
strain
l
lacti
htra
pnzpnisa
secllo
secllo
also
collect
use
cold
trichloroacet
acid
tca
precipit
wv
final
concentr
previous
describ
western
blot
analysi
gel
blot
nitrocellulos
membran
hybondecl
tm
amersham
bioscienc
uk
ltd
membran
block
overnight
c
skim
milk
tb
buffer
sodium
chlorid
mm
trishcl
ph
primari
rabbit
antillo
antibodi
diatheva
itali
secondari
antirabbit
antibodi
ecl
western
blot
system
use
dilut
skim
milk
respect
western
blot
detect
perform
use
amersham
ecl
western
blot
system
amersham
bioscienc
uk
ltd
accord
protocol
recommend
manufactur
sinc
anim
vaccin
nisininduc
vaccin
strain
requir
continu
vivo
express
llo
vitro
induct
period
examin
kinet
llo
product
follow
remov
nisin
induc
two
nisininduc
strain
induc
nisin
h
wash
three
time
pb
resuspend
fresh
broth
llo
product
analyz
time
western
blot
histag
llo
purifi
cell
lysat
cytollo
pnzpnisa
cytollo
acellular
supernat
pnzpnisa
secllo
secllo
mean
ninta
gel
affin
chromatographi
cell
lysat
pass
ninta
gel
qiagen
pack
chromatographi
column
biorad
llo
purifi
use
procedur
describ
qiagen
qiaexpressionist
tm
similar
procedur
use
secret
llo
pnzpnisa
secllo
secllo
supernat
ph
first
adjust
ph
use
naoh
pass
ninta
gel
assess
llo
produc
activ
form
hemolyt
activ
prepar
check
use
method
describ
kohda
et
al
modif
briefli
aliquot
l
vv
sheep
red
blood
cell
rbc
suspend
pb
ph
distribut
ml
eppendorf
tube
twofold
serial
dilut
pb
ph
purifi
llo
nonsecret
llo
dialyz
cultur
supernat
secret
llo
ad
tube
final
volum
ml
posit
control
distil
water
neg
control
pb
ph
also
includ
tube
incub
static
c
min
centrifug
supernat
collect
absorb
measur
nm
hemolyt
unit
calcul
purifi
llo
pnzpnisa
cytollo
one
hemolyt
unit
hu
defin
amount
llo
requir
caus
hemoglobin
releas
sheep
rbc
compar
hemoglobin
releas
posit
control
distil
water
secret
llo
hemolyt
activ
express
term
complet
hemolyt
unit
chu
defin
reciproc
highest
dilut
supernat
show
complet
hemolysi
noteworthi
fail
detect
llo
product
lactococcu
cytollo
strain
previou
detect
techniqu
consequ
subsequ
experi
involv
three
remain
lloproduc
strain
intracellular
growth
construct
l
lacti
strain
investig
macrophagelik
cell
describ
previous
modif
briefli
cell
normal
grown
dmem
glutamax
medium
gibco
contain
foetal
calf
serum
fc
c
co
test
cell
grown
h
tissu
cultur
plate
sarstedt
lactococcu
strain
wash
twice
pb
hnisin
induct
od
induc
strain
od
control
l
lacti
htra
strain
constitut
htra
secllo
strain
l
monocytogen
egd
also
includ
posit
control
wash
strain
suspend
cultur
medium
ie
dmem
glutamax
plu
fc
ad
well
contain
cell
multipl
infect
moi
bacteri
cell
per
cell
plate
incub
h
remov
growth
medium
follow
singl
wash
fresh
warm
medium
addit
fresh
medium
contain
gml
gentamicin
kill
extracellular
bacteria
plate
incub
h
cell
lyse
releas
intracellular
bacteria
timepoint
h
sampl
use
l
cold
steril
distil
water
follow
dilut
plate
onto
appropri
agar
media
gentamicincontain
medium
remov
remain
well
fresh
medium
ad
plate
incub
anoth
h
follow
time
bacteri
count
similarli
determin
sampl
femal
balbc
mice
week
age
use
anim
experi
anim
procedur
review
approv
ethic
assess
committe
univers
colleg
cork
ucc
anim
divid
group
five
mice
group
given
eight
dose
three
lloproduc
strain
either
oral
gavag
intraperiton
inject
day
l
lacti
group
oral
ip
nontreat
group
includ
neg
control
group
treat
subleth
ip
l
monocytogen
egd
cfumous
total
six
dose
weekli
basi
also
includ
posit
control
inocul
dose
cfumous
oral
experi
ip
rout
dose
cfumous
given
day
respect
follow
booster
dose
cfumous
gradual
increas
ip
inocul
dose
intend
avoid
possibl
advers
effect
associ
parenter
administr
high
dose
bacteria
mice
two
induc
strain
grown
od
broth
gml
cm
induc
nisin
vv
h
wash
twice
pb
resuspend
pb
prior
inocul
constitut
llosecret
strain
l
lacti
htra
secllo
overnight
cultur
inocul
fresh
broth
contain
gml
cm
grown
od
point
cell
harvest
wash
twice
pb
resuspend
pb
inocul
final
dose
volum
per
mous
l
oral
ip
inocul
elispot
test
use
describ
previous
detect
cytotox
cell
specif
restrict
llo
epitop
llo
gykdgneyi
peptid
protein
research
uk
mous
mastocytoma
line
cell
european
collect
cell
cultur
ecacc
use
antigen
present
cell
apc
cell
puls
llo
peptid
nonpuls
use
stimul
splenocyt
isol
mice
vaccin
regimen
number
llo
specif
cell
count
use
stereomicroscop
titr
llospecif
antibodi
determin
sera
treat
mice
control
group
use
elisa
previous
describ
briefli
elisa
plate
costar
corn
incorpor
coat
overnight
c
l
per
well
gml
llo
purifi
ninta
affin
chromatographi
cell
lysat
e
coli
harbor
induct
mm
isopropyl
iptg
h
room
temperatur
shake
plate
wash
pb
contain
tween
sigma
pbst
block
h
skim
milk
wash
dilut
serum
sampl
ad
h
room
temperatur
follow
wash
pbst
addit
horseradish
peroxidas
hrp
conjug
rat
antimous
bd
bioscienc
h
room
temperatur
detect
perform
use
hrp
substrat
tetramethylbenzidin
tmb
reaction
stop
addit
sulfur
acid
absorb
measur
nm
titr
defin
serum
dilut
reciproc
calcul
regress
equat
linear
part
curv
obtain
plot
serum
dilut
absorb
absorb
equal
doubl
standard
deviat
highest
absorb
valu
observ
neg
control
group
listeri
challeng
perform
previous
describ
briefli
mice
challeng
specifi
period
day
week
last
vaccin
booster
intraperiton
inject
l
cfuml
ie
cfumous
luminesc
l
monocytogen
egd
tabl
luminesc
strain
recent
character
prove
ident
growth
characterist
wild
type
mice
euthan
day
postchalleng
listeri
burden
determin
spleen
liver
measur
wholeorgan
luminesc
xenogen
machin
xenogen
alameda
ca
follow
organ
homogen
serial
dilut
plate
bhi
agar
plate
contain
gml
cm
plate
incub
c
day
listeria
count
calcul
per
organ
limit
detect
lod
listeria
cfuorgan
student
ttest
use
statist
analysi
data
result
p
valu
less
consid
statist
signific
ninta
gel
purif
histag
llo
sdspage
follow
western
blot
use
polyclon
rabbit
antillo
reveal
effici
llo
product
three
strain
l
lacti
pnzpnisa
cytollo
l
lacti
htra
pnzpnisa
secllo
l
lacti
htra
secllo
fig
histag
llo
found
cell
lysat
fraction
c
cultur
supernat
secret
fraction
fig
induc
pnzpnisa
cytollo
llosecret
strain
htra
harbor
secllo
pnzpnisa
secllo
western
blot
antillo
antibodi
show
posit
band
c
fraction
fig
histag
llo
could
isol
ninta
chromatographi
c
fraction
htra
pnzpnisa
secllo
indic
presenc
along
precursor
secllo
data
shown
contrari
histag
llo
could
isol
c
fraction
htra
secllo
suggest
presenc
precursor
intracellularli
data
shown
llo
could
detect
case
l
lacti
cytollo
though
dna
sequenc
confirm
correct
lark
technolog
inc
uk
analysi
logphas
stationaryphas
cell
lysat
cell
pellet
bound
llo
cultur
supernat
l
lacti
cytollo
fail
detect
llo
data
shown
consequ
subsequ
anim
experi
conduct
three
strain
capabl
effici
llo
express
llo
produc
three
strain
show
detect
hemolyt
activ
confirm
express
latter
find
like
relat
level
secret
llo
much
lower
case
l
lacti
htra
secllo
fig
valu
hemolyt
activ
similar
obtain
llo
express
vector
two
nisininduc
strain
examin
continu
llo
product
upon
remov
nisin
h
induct
period
found
two
strain
continu
product
llo
vitro
indic
signific
accumul
protein
five
hour
period
data
shown
similar
result
demonstr
bermudezhumaran
et
al
nisininduc
lactococci
consequ
induc
strain
treat
nisin
h
rather
h
intracellular
growth
assay
anim
inocul
assess
bacteri
growth
cell
treat
bacteri
strain
plate
count
perform
posttreat
period
bacteri
count
wildtyp
l
monocytogen
increas
significantli
p
count
threello
produc
strain
along
neg
control
l
lacti
htra
decreas
significantli
p
twofold
data
shown
result
demonstr
incap
lactococcu
strain
longterm
surviv
macrophag
cell
elispot
assay
use
analyz
develop
llospecif
cell
mous
mastocytoma
cell
use
antigen
present
cell
express
restrict
mhc
class
molecul
result
spot
would
due
llospecif
cell
shortterm
immun
respons
assess
day
last
booster
ip
oral
rout
three
strain
demonstr
llo
specif
spot
follow
ip
inocul
fig
spot
observ
follow
oral
inocul
data
shown
l
lacti
htra
pnzpnisa
secllo
induc
secret
llo
show
greatest
propens
stimul
llo
specif
cell
compar
two
vaccin
strain
fig
serum
antibodi
titr
measur
day
final
vaccin
booster
use
llospecif
elisa
l
lacti
htra
pnzpnisa
secllo
could
elicit
llospecif
serum
indic
helper
type
immun
respons
indic
helper
type
immun
respons
ip
fig
oral
data
shown
rout
howev
titr
statist
signific
oral
rout
although
l
lacti
htra
secllo
produc
detect
titr
ip
rout
titr
ip
fig
oral
data
shown
rout
titr
ip
rout
statist
signific
fig
statist
signific
antibodi
titr
observ
l
lacti
pnzpnisa
cytollo
either
oral
data
shown
ip
rout
fig
note
poor
oral
infect
l
monocytogen
murin
model
prevent
use
oral
challeng
studi
mice
therefor
challeng
intraperiton
luminesc
l
monocytogen
day
final
vaccin
booster
mimic
system
phase
infect
three
day
follow
challeng
mice
euthan
luminesc
individu
organ
measur
use
xenogen
machin
xenogen
alameda
ca
follow
plate
determin
listeria
count
liver
spleen
bacteri
count
result
follow
ip
vaccin
reveal
signific
protect
evidenc
low
listeri
count
spleen
liver
mice
vaccin
either
three
lloproduc
strain
fig
contrari
strong
luminesc
high
listeri
count
observ
organ
nontreat
group
group
treat
control
strain
l
lacti
howev
found
mice
treat
control
strain
l
lacti
show
significantli
lower
listeri
organ
count
p
nontreat
mice
indic
nonspecif
immun
protect
l
monocytogen
l
lacti
strain
fig
result
challeng
experi
day
ip
immun
regimen
mous
group
n
ip
vaccin
day
challeng
ip
luminesc
listeria
monocytogen
day
mice
euthan
day
later
listeria
count
spleen
liver
p
p
student
ttest
compar
neg
control
group
error
bar
repres
mean
sem
lod
limit
detect
test
nd
detect
fig
signific
differ
observ
oral
vaccin
group
neg
control
group
three
strain
data
shown
summari
best
protect
attain
follow
inocul
induc
llosecret
strain
l
lacti
htra
pnzpnisa
secllo
via
ip
rout
fig
result
reflect
previou
elispot
fig
antibodi
titr
fig
result
particular
strain
elicit
highest
number
llo
specif
spot
llospecif
serum
antibodi
respect
strain
elicit
statist
signific
protect
ip
listeria
challeng
given
oral
vaccin
howev
analysi
liver
count
demonstr
p
valu
data
shown
indic
approach
oral
vaccin
may
warrant
studi
sinc
l
lacti
htra
pnzpnisa
secllo
show
best
protect
result
short
term
ip
rout
strain
investig
longer
term
vaccin
studi
week
follow
last
booster
moreov
assum
rapid
death
lactococcu
due
gastric
acid
suggest
vitro
observ
data
shown
might
major
caus
vaccin
failur
given
oral
therefor
repeat
oral
vaccin
final
inoculum
resuspend
broth
ph
adjust
mm
co
sodium
bicarbon
l
lacti
htra
pnzpnisa
secllo
strain
given
oral
ip
rout
use
previous
describ
vaccin
regimen
elispot
test
serum
titr
challeng
test
perform
week
last
booster
llo
specif
lymphocyt
detect
follow
ip
oral
ph
vaccin
regimen
fig
similarli
statist
signific
titr
detect
follow
administr
ip
oral
vaccin
fig
final
challeng
experi
confirm
protect
efficaci
inject
l
lacti
htra
pnzpnisa
secllo
strain
fig
differ
listeri
organ
count
observ
group
treat
control
l
lacti
htra
nontreat
group
indic
lack
nonspecif
immun
stimul
week
postvaccin
fig
repres
organ
luminesc
pictur
challeng
experi
shown
fig
noteworthi
found
sensit
luminesc
detect
limit
cfuorgan
luminesc
could
measur
find
confin
use
luminesc
data
qualit
rather
quantit
comparison
shortand
longterm
challeng
experi
result
confirm
ip
inocul
confer
longer
term
protect
week
last
booster
specif
immun
antibodi
cytotox
cell
moreov
shown
oral
inocul
ph
promot
vaccin
efficaci
suggest
gastrointestin
condit
eg
presenc
bile
may
contribut
reduc
viabil
lactococcu
gastrointestin
transit
l
lacti
propos
safe
effect
vaccin
deliveri
platform
deliveri
heterolog
antigen
immun
system
examin
number
approach
overexpress
major
immunodomin
antigen
llo
l
monocytogen
l
lacti
analyz
protect
antilisteri
immun
respons
murin
infect
model
investig
efficaci
llo
express
l
lacti
gene
place
control
constitut
promot
region
induc
pnisa
promot
region
promot
also
examin
effect
protein
secret
upon
protect
efficaci
lactococcusbas
vaccin
strain
previou
work
laboratori
optimis
detect
method
examin
express
level
nonsecret
llo
l
lacti
pnzpnisa
cytollo
manuscript
submit
howev
intracellular
llo
express
rel
weak
constitut
promot
cytollo
could
detect
present
studi
llo
clearli
nontox
system
sequenc
construct
valid
data
shown
exact
reason
lack
detect
llo
protein
construct
unclear
degrad
toxic
effect
intracellularli
express
heterolog
protein
l
lacti
previous
report
thu
current
clone
express
work
creat
three
potenti
l
lacti
vaccin
strain
express
llo
examin
intracellular
growth
three
l
lacti
vaccin
strain
macrophagelik
cell
determin
bacteri
count
variou
time
interv
model
l
lacti
incap
growth
cell
evidenc
experiment
bacteri
count
irrespect
llo
express
contrast
significantli
l
monocytogen
control
increas
number
time
listeriolysin
essenti
escap
l
monocytogen
macrophag
phagosom
cytoplasm
compart
shown
previous
engin
llosecret
bacillu
subtili
strain
escap
phagosom
compart
grow
cell
cytosol
contrast
goetz
et
al
util
microinject
introduc
varieti
bacteria
directli
cytoplasm
cell
found
bacteria
adapt
cytoplasm
compart
unabl
multipli
grow
work
support
latter
find
suggest
l
lacti
vaccin
vector
engin
access
cytoplasm
antigen
present
pathway
incap
growth
environ
unlik
l
monocytogen
lactococcu
adapt
multipli
persist
insid
macrophag
possess
molecular
factor
enabl
surviv
host
cytosol
noteworthi
llo
rapidli
inactiv
cytosol
infect
cell
display
toxic
toward
host
cytoplasm
membran
hypothes
lloexpress
l
lacti
strain
access
cytoplasm
mhc
class
antigen
present
pathway
antigen
present
cell
deliv
llo
antigen
previous
determin
provid
protect
immun
l
monocytogen
measur
serum
titr
two
igg
isotyp
reflect
humor
helper
type
respons
reflect
cellmedi
helper
type
respons
although
signific
antibodi
titr
elicit
two
vaccin
strain
fig
result
challeng
test
suggest
respons
import
protect
significantli
anoth
studi
found
cell
antibodi
cell
major
mediat
immun
listeria
llo
deliv
attenu
b
anthraci
strain
data
also
suggest
futur
l
lacti
vector
express
llo
combin
heterolog
antigen
may
use
elicit
antibodymedi
well
cellmedi
immun
respons
engin
l
lacti
strain
capabl
elicit
specif
cell
domin
llo
epitop
cell
respons
signific
vaccin
strain
induc
lower
level
specif
cell
posit
control
subleth
l
monocytogen
howev
engin
l
lacti
strain
provid
protect
immun
secondari
challeng
l
monocytogen
clear
literatur
robust
tcell
respons
requir
immun
l
monocytogen
level
llospecif
cell
gener
vaccin
engin
l
lacti
suffici
elicit
enhanc
clearanc
l
monocytogen
rel
control
mice
inocul
control
l
lacti
overal
greatest
respons
gener
llosecret
nisininduc
strain
htra
pnzpnisa
secllo
also
gener
highest
llo
express
level
vitro
fig
addit
report
literatur
secret
llo
immunogen
nonsecret
form
util
strain
longer
term
vaccin
studi
analyz
protect
immun
respons
week
follow
final
booster
inocul
studi
demonstr
vaccin
vector
capabl
induc
specif
protect
subsequ
l
monocytogen
infect
vector
capabl
induc
immun
level
exposur
subleth
l
monocytogen
posit
control
like
due
fact
current
l
lacti
vector
express
singl
l
monocytogen
antigen
ie
llo
previou
studi
util
salmonella
enterica
serovar
typhimurium
express
llo
listeri
antigen
show
enhanc
protect
listeriosi
compar
vector
express
singl
antigen
l
lacti
repeatedli
employ
mucos
intranas
oral
vaccin
deliveri
vehicl
howev
viabil
lactococcu
wellknown
greatli
diminish
gastrointestin
tract
thu
llo
product
present
immun
system
expect
reduc
environ
attempt
maxim
oral
dose
lactococcu
buffer
vaccin
inocula
ph
increas
number
vaccin
dose
compens
loss
similar
approach
use
investig
use
seven
nine
oral
dose
variou
vaccin
regimen
howev
present
studi
obtain
signific
protect
l
monocytogen
follow
oral
vaccin
reason
may
wellreport
rapid
kill
l
lacti
gut
vaccin
regimen
use
natur
express
antigen
combin
factor
studi
strategi
improv
vaccin
efficaci
via
oral
rout
ongo
laboratori
number
host
carrier
previous
examin
heterolog
express
llo
act
live
vaccin
l
monocytogen
attenu
b
anthraci
strain
use
live
llosecret
vaccin
vector
listeria
via
subcutan
rout
could
elicit
llospecif
respons
antillo
antibodi
provid
partial
protect
l
monocytogen
challeng
recombin
attenu
aroa
typhimurium
strain
produc
llo
also
investig
vaccin
candid
listeriosi
aroa
typhimurium
strain
produc
secret
llo
strain
produc
intracellular
llo
found
protect
listeria
challeng
anoth
studi
typhimurium
express
llo
fuse
yersinia
outer
protein
e
yope
carrier
molecul
cytosol
deliveri
use
typhimurium
type
iii
secret
system
oral
vaccin
strain
elicit
llo
specif
cell
protect
immun
upon
listeri
challeng
llo
welldescrib
antigen
l
monocytogen
protein
also
play
role
lysi
phagosom
membran
therefor
permit
entri
antigen
cytoplasm
antigen
process
pathway
concept
llo
redirect
accompani
antigen
toward
mediat
immun
respons
well
establish
literatur
llosecret
mycobacterium
bovi
bcg
strain
abl
increas
protect
efficaci
vaccin
tuberculosi
due
better
antigen
present
cytosol
mhc
class
pathway
addit
e
coli
cell
express
llo
ovalbumin
ova
demonstr
enhanc
deliveri
ova
k
b
restrict
epitop
siinfekl
mhc
class
present
could
protect
mice
upon
challeng
ovaexpress
melanoma
cell
line
similarli
mhc
class
process
ova
macrophag
could
improv
typhimurium
dualli
express
llo
ova
use
l
lacti
llovector
number
signific
advantag
propos
platform
describ
attenu
mutant
l
monocytogen
l
lacti
foodgrad
nonpathogen
bacterium
safeti
profil
wellestablish
unlik
gramneg
vector
l
lacti
produc
endotoxin
time
innat
immunostimulatori
effect
llo
enhanc
access
cytoplasm
process
pathway
propos
l
lactisexpress
llo
may
also
provid
safe
platform
deliveri
heterolog
antigen
includ
viral
tumour
antigen
gener
specif
memori
effector
cell
respons
conclus
develop
engin
l
lacti
strain
capabl
produc
activ
llo
immunodomin
protein
antigen
l
monocytogen
one
vector
strain
particular
capabl
secret
prolong
high
level
llo
follow
induct
nisin
gener
protect
immun
l
monocytogen
challeng
defin
antillo
cell
approach
may
inform
develop
safe
antilisteri
vaccin
protect
zoonot
diseas
affect
human
also
domest
anim
listeriosi
result
signific
loss
